InvestorsHub Logo
Followers 375
Posts 16969
Boards Moderated 4
Alias Born 03/07/2014

Re: Gaintrader post# 6744

Thursday, 04/03/2014 6:13:21 PM

Thursday, April 03, 2014 6:13:21 PM

Post# of 106837
Dated 3/4/14? "Breaking news"? It's April 4th tomorrow. Any updates on MIRROR, rather than the 5 person, phase I, Mexico "Angel" trial?

Why start over, waste money/resources of which you have very little (5 employees, maybe a a few $hundred thous cash at any given time, total R&D last yr of about $600K which is what, about $50K a month per last 10-K) on going back to phase I, when you have a phase III called Mirror and a phase II/III called Marvel, Marvel now being about 4 plus yrs old and gone nowhere? All for essentially the same product line, key product? Doesn't make sense IMO?

It's a long, long ways from a phase I, to get to a phase III and beyond. Baxter is doing a phase III, stem-cell-heart related trial right now, listed on clinicaltrials.gov, and it began in 2012 and shows an "expected" end date, just for final data of 2016. That's 4 yrs in my book. That's just the phase III portion. There was probably 1 to 2 yrs more for the initial phase I ,then phase II to get to that phase III. So that's about 6 or 7 yrs total.

Why post old news about Angel? It's been posted many times before already? Curious/interesting IMO?